Oxford Biomedica PLC 2017 Annual Report with Sustainability Disclosures
Company: Oxford Biomedica PLC
Sector: Professional & technical services
Country: United Kingdom
Year: 2017
Type: Annual Report with Sustainability Disclosures
Pages: 140
The report presents 2017 as a significant commercial transition year for the company, marked by the US approval of Novartis' Kymriah, the first LentiVector-enabled product. Consolidated revenue reached £37,590 thousand and year-end headcount increased to 321. The report also discloses 2017 environmental usage data and estimated total CO2 emissions of 2472 tonnes.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.